BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23940574)

  • 21. Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
    Honrado E; Osorio A; Palacios J; Milne RL; Sánchez L; Díez O; Cazorla A; Syrjakoski K; Huntsman D; Heikkilä P; Lerma E; Kallioniemi A; Rivas C; Foulkes WD; Nevanlinna H; Benítez J
    J Clin Oncol; 2005 Oct; 23(30):7503-11. PubMed ID: 16234517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.
    Garcia K; Blank JL; Bouck DC; Liu XJ; Sappal DS; Hather G; Cosmopoulos K; Thomas MP; Kuranda M; Pickard MD; Liu R; Bandi S; Smith PG; Lightcap ES
    Mol Cancer Ther; 2014 Jun; 13(6):1625-35. PubMed ID: 24672057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of DNA repair pathways in cisplatin resistant lung cancer.
    O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.
    Jayachandran G; Ueda K; Wang B; Roth JA; Ji L
    PLoS One; 2010 Aug; 5(8):e11994. PubMed ID: 20700484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Nucleotide Excision Repair in Cisplatin Resistance.
    Duan M; Ulibarri J; Liu KJ; Mao P
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2.
    Chen X; Chen F; Ren Y; Weng G; Xu L; Xue X; Keng PC; Lee SO; Chen Y
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1471-1484. PubMed ID: 31020420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aluminium chloride and aluminium chlorohydrate on DNA repair in MCF10A immortalised non-transformed human breast epithelial cells.
    Farasani A; Darbre PD
    J Inorg Biochem; 2015 Nov; 152():186-9. PubMed ID: 26319584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
    Turan V; Oktay K
    Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
    Wansleben S; Davis E; Peres J; Prince S
    Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation.
    Ray A; Mir SN; Wani G; Zhao Q; Battu A; Zhu Q; Wang QE; Wani AA
    Mol Cell Biol; 2009 Dec; 29(23):6206-19. PubMed ID: 19805520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.
    Fang M; Xia F; Mahalingam M; Virbasius CM; Wajapeyee N; Green MR
    Mol Cell Biol; 2013 Jul; 33(13):2635-47. PubMed ID: 23648481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide excision repair deficiency in melanoma in response to UVA.
    Murray HC; Maltby VE; Smith DW; Bowden NA
    Exp Hematol Oncol; 2015; 5():6. PubMed ID: 26913219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.
    Ray A; Blevins C; Wani G; Wani AA
    PLoS One; 2016; 11(7):e0159344. PubMed ID: 27442013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.
    De la Torre C; Pincheira J; López-Sáez JF
    Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
    Wójcicka A; Czetwertyńska M; Świerniak M; Długosińska J; Maciąg M; Czajka A; Dymecka K; Kubiak A; Kot A; Płoski R; de la Chapelle A; Jażdżewski K
    Genes Chromosomes Cancer; 2014 Jun; 53(6):516-23. PubMed ID: 24599715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
    Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
    J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.